Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study

BACKGROUND: The ability of tamoxifen and raloxifene to decrease breast cancer risk varies among different breast cancer subtypes. It is important to determine one’s subtype-specific breast cancer risk when considering chemoprevention. A number of single nucleotide polymorphisms (SNPs), including one...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hannah Lui, Ziogas, Argyrios, Chang, Jenny, Desai, Bhumi, Bessonova, Leona, Garner, Chad, Lee, Eunjung, Neuhausen, Susan L., Wang, Sophia S., Ma, Huiyan, Clague, Jessica, Reynolds, Peggy, Lacey, James V., Bernstein, Leslie, Anton-Culver, Hoda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711015/
https://www.ncbi.nlm.nih.gov/pubmed/26758508
http://dx.doi.org/10.1186/s12885-015-2036-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711015/
https://www.ncbi.nlm.nih.gov/pubmed/26758508
http://dx.doi.org/10.1186/s12885-015-2036-9

Ejemplares similares